Increasing Efficiency and Productivity in Bioanalysis
From our September 1 issue: Chromatin...
From our September 1 issue: Celgene,...
From our September 1 issue: Rummaging...
These politicians accepted the most pharma dollars toward their campaigns. [© Ljupco Smokovski - Fotolia.com]
Total contributions: $93,250
Total contributions: $104,950
Total contributions: $112,000
Total contributions: $116,500
Total contributions: $116,830
Total contributions: $122,050
Total contributions: $123,953
Total contributions: $159,400
Total contributions: $162,865
Total contributions: $173,500
Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!
Do you think all new cancer drugs awaiting approval should undergo value-pricing?
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved